Davis Polk advised the representatives of the several underwriters in the offering. Natera, Inc. announced its follow-on offering of 11,430,000 shares of common stock for total gross...
You must be a Standard 1 Year member to access this content.
Davis Polk advised Novo Nordisk on the deal while Goodwin Procter represented Forma Therapeutics. Novo Nordisk announced its approximately $1.1 billion acquisition of Forma Therapeutics. Under the...
You must be a Standard 1 Year member to access this content.
Davis Polk advised Smith+Nephew on its acquisition of Engage Surgical. The cost of the acquisition is up to $135 million contingent on sales performance. Smith+Nephew is...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Senti Biosciences, while Davis Polk advised Dynamics Special Purpose Corp. on the deal. Senti Biosciences (“Senti Bio”) announced its definitive business combination agreement with...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Iris Energy, while Davis Polk advised the representatives of the several underwriters in the IPO. Clifford Chance advised Australian company Iris Energy...
You must be a Standard 1 Year member to access this content.
Davis Polk advised Marathon Digital, while Latham & Watkins represented the initial purchasers in the offering. Marathon Digital Holdings, Inc., one of the largest enterprise Bitcoin...
You must be a Standard 1 Year member to access this content.
Davis Polk & Wardwell LLP, Haiwen & Partners and Ogier served as legal advisors to Blue Safari. Blue Safari Group Acquisition Corp. (Nasdaq: BSGA), a publicly traded...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the joint book-running managers and representatives of the several underwriters in the offering. IVERIC bio Inc. executed a $173.4 million SEC-registered offering of 10,350,000 shares...
You must be a Standard 1 Year member to access this content.
Olshan Frome Wolosky represented P10 in the transaction, while Davis Polk advised the representatives of the several underwriters. P10, Inc., a leading private markets solutions provider, announced...
You must be a Standard 1 Year member to access this content.
Davis Polk is advised Regions Bank on the transaction, while Kramer Levin advised Sabal. Regions Bank announced its acquisition of Sabal Capital Partners. The transaction is...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the representatives of the several underwriters in the offering. Adagio Therapeutics, Inc. executed the initial public offering of 20,930,000 shares of its common stock at...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised Vaccitech on the deal, while Davis Polk advised the representatives of the several underwriters. Vaccitech (Nasdaq: VACC) announced its initial public offering...
You must be a Standard 1 Year member to access this content.
